What is the Impact Factor of Journal of Diabetes and Metabolic Disorders?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Journal of Diabetes and Metabolic Disorders is 2.10, ranking in quartile Q3 of Web of Science (ESCI).

Is Journal of Diabetes and Metabolic Disorders indexed in Web of Science or Scopus?

Yes, Journal of Diabetes and Metabolic Disorders is indexed in Web of Science (ESCI, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.583 (Q2) and an H-index of 53.

Who publishes Journal of Diabetes and Metabolic Disorders and what is the Article Processing Charge (APC)?

Journal of Diabetes and Metabolic Disorders is published by Springer Nature. The estimated Article Processing Charge (APC) is approximately $3,000 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Journal of Diabetes and Metabolic Disorders?

The official ISO-4 abbreviation of Journal of Diabetes and Metabolic Disorders is "dmed". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS ESCI Q3Scopus Q2SCImago #10,154Hybrid

Journal of Diabetes and Metabolic Disorders

Acronym:dmed

•

Identifier (ISSN):2251-6581(Print)

•

Publisher:Springer Nature

Clarivate JCR Index Advisory: Active (ESCI)

Official Website Submission Portal Compare

Clarivate IF (2026)

2.1↑ +0.5

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS ESCIJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Journal of Diabetes and Metabolic Disorders

WoS Q3

Annual Impact Factor Metric

Current (2026):2.1

Scopus SJR & RankScopus Q2

0.583

#10,154

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

53 papers with at least that number of citations each

WoS: ESCIQ3

Self-Citation Rate5.6%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

228articles/year

10.77% Gold OA•76.79% Original Research

Aims & Scope

Journal of Diabetes & Metabolic Disorders is a peer reviewed journal which publishes original clinical and translational articles and reviews in the field of endocrinology and provides a forum of debate of the highest quality on these issues. Topics of interest include, but are not limited to, diabetes, lipid disorders, metabolic disorders, osteoporosis, interdisciplinary practices in endocrinology, cardiovascular and metabolic risk, aging research, obesity, traditional medicine, pychosomatic research, behavioral medicine, ethics and evidence-based practices.As of Jan 2018 the journal is published by Springer as a hybrid journal with no article processing charges. All articles published before 2018 are available free of charge on springerlink.Unofficial 2017 2-year Impact Factor: 1.816.

Topics Covered (Recognized by AI)

Medicine99.6%Biology97.4%Endocrinology91.5%Internal medicine91%Diabetes mellitus81.7%Pathology69.6%Chemistry54.8%Biochemistry53.2%Genetics36.7%Mathematics32.3%Biotechnology31.7%Insulin30.8%Type 2 diabetes30.7%Statistics29.3%Psychology28.8%Obesity28.2%Sociology28%Surgery21.5%Environmental health20.8%Demography20.7%

Primary Research Areas

Medicine Internal Medicine

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRESCI2026

ENDOCRINOLOGY & METABOLISM

Rank148/198

IndexESCI

JCIESCI2026

ENDOCRINOLOGY & METABOLISM

Rank158/198

IndexESCI

Category	Index	Rank	Quartile
ENDOCRINOLOGY & METABOLISM	JCRESCI	148/198	Q3
ENDOCRINOLOGY & METABOLISM	JCIESCI	158/198	Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.1

Articles / Year257

Total Citations113

2025

IF1.6

Articles / Year277

Total Citations632

2024

IF1.8

Articles / Year167

Total Citations770

2023

IF2.8

Articles / Year194

Total Citations1,142

2022

IF—

Articles / Year235

Total Citations2,226

Year	Impact Factor	Articles / Year	Total Citations
2026	2.1	257	113
2025	1.6	277	632
2024	1.8	167	770
2023	2.8	194	1,142
2022	—	235	2,226
2021	—	240	3,378
2020	—	213	5,689
2019	—	95	1,865
2018	—	46	884
2017	—	49	2,477
2016	—	19	504
2015	—	129	3,462

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,154Scopus Q2SCImago Profile

Scopus Coverage:2012-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q2

0.583

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.15

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,000 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,394

3-Year Documents586

Citable Documents572

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate47.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Internal MedicineQ2

Endocrinology, Diabetes and MetabolismQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 5.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区ENDOCRINOLOGY & METABOLISM

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Journal of Diabetes and Metabolic Disorders (acronym: dmed, ISSN: 2251-6581) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer Nature in United Kingdom. The periodical holds a Journal Impact Factor (JIF) of 2.10, ranking in quartile Q3 of Web of Science (ESCI), a Scopus SJR indicator of 0.583 (Q2), an H-index of 53.

The journal enforces rigorous peer evaluation with a publication frequency of 2 issues per year, an annual output of approximately 228 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,000 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.